Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 6;21(7):269.
doi: 10.1208/s12249-020-01814-w.

Towards a Continuous Manufacturing Process of Protein-Loaded Polymeric Nanoparticle Powders

Affiliations

Towards a Continuous Manufacturing Process of Protein-Loaded Polymeric Nanoparticle Powders

Stefan Schiller et al. AAPS PharmSciTech. .

Abstract

To develop a scalable and efficient process suitable for the continuous manufacturing of poly(lactic-co-glycolic acid) (PLGA) nanoparticles containing ovalbumin as the model protein. PLGA nanoparticles were prepared using a double emulsification spray-drying method. Emulsions were prepared using a focused ultrasound transducer equipped with a flow cell. Either poly(vinyl alcohol) (PVA) or poloxamer 407 (P-407) was used as a stabilizer. Aliquots of the emulsions were blended with different matrix excipients and spray dried, and the yield and size of the resuspended nanoparticles was determined and compared against solvent displacement. Nanoparticle sizes of spray-dried PLGA/PVA emulsions were independent of the matrix excipient and comparable with sizes from the solvent displacement method. The yield of the resuspended nanoparticles was highest for emulsions containing trehalose and leucine (79%). Spray drying of PLGA/P-407 emulsions led to agglomerated nanoparticles independent of the matrix excipient. PLGA/P-407 nanoparticles pre-formed by solvent displacement could be spray dried with limited agglomeration when PVA was added as an additional stabilizer. A comparably high and economically interesting nanoparticle yield could be achieved with a process suitable for continuous manufacturing. Further studies are needed to understand the robustness of a continuous process at commercial scale.

Keywords: PLGA nanoparticles; continuous manufacturing; focused ultrasound; protein delivery; spray drying.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Resulting nanoparticle sizes after spray drying of PLGA/PVA double emulsions with and without the addition of different matrix excipients. Spray-dried powders were reconstituted in purified water, then aggregates were removed by filtration, and particle size distribution was measured by dynamic light scattering. Nanoparticles precipitated by solvent displacement without spray drying served as the control. Measurements were done in triplicate, RSD < 0.5%
Fig. 2
Fig. 2
Resulting nanoparticle yield after spray drying of PLGA/PVA double emulsions with and without the addition of different matrix excipients. Nanoparticles were isolated from the matrix after reconstitution of the complete batch in purified water, then aggregates were removed by filtration, and the mass was determined after drying
Fig. 3
Fig. 3
Resulting nanoparticle sizes after spray drying of PLGA/P-407 double emulsions with and without the addition of different matrix excipients. Spray-dried powders were reconstituted in purified water, then aggregates were removed by filtration, and particle size distribution was measured by dynamic light scattering. Nanoparticles precipitated by solvent displacement without spray drying served as the control. Measurements were done in triplicate, RSD < 0.5%
Fig. 4
Fig. 4
Resulting nanoparticle yield after spray drying of PLGA/P-407 double emulsions with and without the addition of different matrix excipients. Nanoparticles were isolated from the matrix after reconstitution of the complete batch in purified water, then aggregates were removed by filtration, and the mass was determined after drying. The nanoparticle yield with K30 was too low to determine by weighing and, as such, is reported as 0

References

    1. Lavik E, von Recum H. The role of Nanomaterials in translational medicine. ACS Nano. 2011;5(5):3419–3424. doi: 10.1021/nn201371a. - DOI - PMC - PubMed
    1. Valencia PM, Farokhzad OC, Karnik R, Langer R. Microfluidic technologies for accelerating the clinical translation of nanoparticles. Nat Nanotechnol. 2012;7(10):623–629. doi: 10.1038/nnano.2012.168. - DOI - PMC - PubMed
    1. Vauthier C, Bouchemal K. Methods for the preparation and manufacture of polymeric nanoparticles. Pharm Res. 2009;26(5):1025–1058. doi: 10.1007/s11095-008-9800-3. - DOI - PubMed
    1. Makgwane PR, Ray SS. Synthesis of nanomaterials by continuous-flow microfluidics: a review. J Nanosci Nanotechnol. 2014;14(2):1338–1363. doi: 10.1166/jnn.2014.9129. - DOI - PubMed
    1. Rietscher R, Thum C, Lehr CM, Schneider M. Semi-automated nanoprecipitation-system-an option for operator independent, scalable and size adjustable nanoparticle synthesis. Pharm Res. 2015;32(6):1859–1863. doi: 10.1007/s11095-014-1612-z. - DOI - PubMed

LinkOut - more resources